@article{31548d8185e9470db730fc36e4bf5ff2,
title = "Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial",
abstract = "In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal transplant recipients (RTR). We evaluated whether higher exposure of EVL could allow a further reduction of CsA.",
keywords = "Adolescent, Adult, Aged, Confidence Intervals, Creatinine, Cyclosporine, Dose-Response Relationship, Drug, Drug Therapy, Combination, Humans, Immunosuppressive Agents, Kidney Transplantation, Living Donors, Middle Aged, Patient Compliance, Patient Selection, Sirolimus, Survival Analysis, Treatment Outcome, Triglycerides, Young Adult, Adolescent, Adult, Aged, Confidence Intervals, Creatinine, Cyclosporine, Dose-Response Relationship, Drug, Drug Therapy, Combination, Humans, Immunosuppressive Agents, Kidney Transplantation, Living Donors, Middle Aged, Patient Compliance, Patient Selection, Sirolimus, Survival Analysis, Treatment Outcome, Triglycerides, Young Adult",
author = "M Salvadori and Mp Scolari and E Bertoni and Franco Citterio and P Rigotti and M Cossu and \{Dal Canton\}, A and G Tisone and A Albertazzi and F Pisani and G Gubbiotti and G Piredda and G Busnach and V Sparacino and V Goepel and P Messa and P Berloco and D Montanaro and P Veroux and S Federico and M Bartezaghi and G Corbetta and C. Ponticelli",
year = "2009",
doi = "10.1097/TP.0b013e3181bb43ec",
language = "English",
volume = "88",
pages = "1194--1202",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
}